Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-10 Sale | 2022-05-12 8:58 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. CAO | 4,200 | $141.5 | $594,300 | 6,315 (Direct) | View |
| 2020-06-15 Sale(A) | 2022-02-11 9:41 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 41,306 | $68.49 | $2,829,152 | 999,914 (Indirect Direct) | View |
| 2020-06-11 Sale(A) | 2022-02-11 9:40 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 50,953 | $65.19 | $3,321,623 | 1,139,915 (Indirect Direct) | View |
| 2022-01-19 Sale | 2022-01-24 06:01 am | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. CAO | 9,375 | $117.01 | $1,097,003 | 13,390 (Direct) | View |
| 2021-12-20 Sale | 2021-12-22 9:51 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. CAO | 1,915 | $123.84 | $237,154 | 8,240 (Direct) | View |
| 2021-12-20 Sale | 2021-12-22 9:51 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | GREGORY JULIA P Director | 12,000 | $125 | $1,500,000 | 0 (Direct) | View |
| 2021-12-14 Sale | 2021-12-16 9:04 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer | 28,858 | $105.37 | $3,040,889 | 54,649 (Indirect Direct) | View |
| 2021-12-10 Sale | 2021-12-10 8:43 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James CFO | 35,000 | $102.55 | $3,589,146 | 94,988 (Direct) | View |
| 2021-11-29 Sale | 2021-12-01 7:24 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 24,525 | $112.8 | $2,766,433 | 1,496,650 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-05-10 Exercise | 2022-05-12 8:58 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. CAO | 2,250 | $53.76 | 6,315 (Direct) | View |
| 2022-05-10 Exercise | 2022-05-12 8:58 pm | N/A 2029-12-05 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. CAO | 2,250 | $0 | 6,315 (Direct) | View |
| 2022-05-11 Option Award | 2022-05-12 8:57 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Antonijevic Irina Director | 5,070 | $0 | 5,070 (Direct) | View |
| 2022-04-28 Option Award | 2022-04-29 9:04 pm | N/A 2032-04-27 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Mehta Kishan Director | 8,239 | $0 | 8,239 (Direct) | View |
| 2022-04-28 Option Award | 2022-04-29 9:03 pm | N/A 2032-04-27 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | GREGORY JULIA P Director | 8,239 | $0 | 8,239 (Direct) | View |
| 2022-04-28 Option Award | 2022-04-29 9:02 pm | N/A 2032-04-27 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | CHILDS JOHN W Director | 8,239 | $0 | 8,239 (Direct) | View |
| 2022-04-28 Option Award | 2022-04-29 9:00 pm | N/A 2032-04-27 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | HUGIN ROBERT J Director | 8,239 | $0 | 8,239 (Direct) | View |
| 2022-04-28 Option Award | 2022-04-29 8:59 pm | N/A 2032-04-27 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Bailey Gregory Director | 8,239 | $0 | 8,239 (Direct) | View |
| 2022-04-28 Option Award | 2022-04-29 8:58 pm | N/A 2032-04-27 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Heffernan Michael Thomas Director | 8,239 | $0 | 8,239 (Direct) | View |
| 2021-12-31 Ownership | 2022-02-11 9:44 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 1,474,051 | $0 | 1,308,989 (Direct) | View |
| 2021-12-31 Ownership | 2022-02-11 9:44 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 170,000 | $0 | 1,308,989 (Indirect) | View |
| 2021-12-31 Ownership | 2022-02-11 9:44 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 0 | $0 | 1,308,989 (Indirect) | View |
| 2021-12-31 Ownership | 2022-02-11 9:15 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Coric Vlad CEO | 47,283 | $0 | 387,985 (Indirect) | View |
| 2021-12-31 Ownership | 2022-02-11 9:15 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Coric Vlad CEO | 0 | $0 | 387,985 (Indirect) | View |
| 2022-01-19 Exercise | 2022-01-24 06:01 am | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. CAO | 3,750 | $53.76 | 13,390 (Direct) | View |
| 2022-01-19 Exercise | 2022-01-24 06:01 am | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. CAO | 1,920 | $32.42 | 13,390 (Direct) | View |
| 2022-01-19 Exercise | 2022-01-24 06:01 am | N/A 2029-12-05 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. CAO | 5,670 | $0 | 13,390 (Direct) | View |
| 2022-01-10 Exercise | 2022-01-12 9:12 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. CAO | 1,000 | $0 | 10,720 (Direct) | View |
| 2022-01-10 Tax Withholding | 2022-01-12 9:12 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. CAO | 464 | $128.87 | 10,720 (Direct) | View |
| 2022-01-10 Exercise | 2022-01-12 9:10 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer | 937 | $0 | 17,402 (Indirect) | View |
| 2022-01-10 Exercise | 2022-01-12 9:04 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Mehta Kishan Director | 1,875 | $0 | 12,515 (Direct) | View |
| 2022-01-07 Option Award | 2022-01-07 9:19 pm | N/A 2032-01-07 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Buten Matthew CFO | 26,000 | $0 | 26,000 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-07 9:18 pm | N/A 2032-01-07 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 10,500 | $0 | 22,176 (Direct) | View |
| 2022-01-06 Exercise | 2022-01-07 9:18 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 2,125 | $0 | 22,176 (Direct) | View |
| 2022-01-06 Tax Withholding | 2022-01-07 9:18 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 551 | $123.86 | 22,176 (Direct) | View |
| 2022-01-06 Tax Withholding | 2022-01-07 9:18 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 342 | $128.87 | 22,176 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-07 9:18 pm | N/A 2032-01-07 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. CAO | 15,000 | $0 | 29,934 (Direct) | View |
| 2022-01-06 Exercise | 2022-01-07 9:18 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. CAO | 1,875 | $0 | 29,934 (Direct) | View |
| 2022-01-06 Tax Withholding | 2022-01-07 9:18 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. CAO | 409 | $123.86 | 29,934 (Direct) | View |
| 2022-01-06 Tax Withholding | 2022-01-07 9:18 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. CAO | 522 | $128.87 | 29,934 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-07 9:18 pm | N/A 2032-01-07 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer | 34,500 | $0 | 64,135 (Direct) | View |
| 2022-01-06 Exercise | 2022-01-07 9:18 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer | 3,750 | $0 | 64,135 (Direct) | View |
| 2022-01-06 Tax Withholding | 2022-01-07 9:18 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer | 1,800 | $123.86 | 64,135 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-07 9:17 pm | N/A 2032-01-07 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly VP | 39,000 | $0 | 58,153 (Direct) | View |
| 2022-01-06 Exercise | 2022-01-07 9:17 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly VP | 3,750 | $0 | 58,153 (Direct) | View |
| 2022-01-06 Tax Withholding | 2022-01-07 9:17 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly VP | 1,800 | $123.86 | 58,153 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-07 9:17 pm | N/A 2032-01-07 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Strategic Advisor | 39,000 | $0 | 71,923 (Direct) | View |
| 2022-01-06 Exercise | 2022-01-07 9:17 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Strategic Advisor | 7,000 | $0 | 71,923 (Direct) | View |
| 2022-01-06 Tax Withholding | 2022-01-07 9:17 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Strategic Advisor | 1,532 | $123.86 | 71,923 (Direct) | View |
| 2022-01-06 Tax Withholding | 2022-01-07 9:17 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Strategic Advisor | 1,279 | $128.87 | 71,923 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-07 9:17 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer | 17,000 | $0 | 81,277 (Direct) | View |
| 2022-01-06 Exercise | 2022-01-07 9:17 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer | 35,250 | $0 | 81,277 (Direct) | View |
| 2022-01-06 Tax Withholding | 2022-01-07 9:17 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer | 1,838 | $123.86 | 81,277 (Direct) | View |
| 2022-01-06 Tax Withholding | 2022-01-07 9:17 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer | 1,539 | $128.87 | 81,277 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-07 9:16 pm | N/A 2032-01-07 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease | 45,000 | $0 | 80,249 (Direct) | View |
| 2022-01-06 Exercise | 2022-01-07 9:16 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease | 8,750 | $0 | 80,249 (Direct) | View |
| 2022-01-06 Tax Withholding | 2022-01-07 9:16 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease | 2,230 | $123.86 | 80,249 (Direct) | View |
| 2022-01-06 Tax Withholding | 2022-01-07 9:16 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease | 1,631 | $128.87 | 80,249 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-07 9:16 pm | N/A 2032-01-07 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Coric Vlad CEO | 110,000 | $0 | 1,122,714 (Direct) | View |
| 2022-01-06 Exercise | 2022-01-07 9:16 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Coric Vlad CEO | 22,500 | $0 | 1,122,714 (Direct) | View |
| 2022-01-06 Tax Withholding | 2022-01-07 9:16 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Coric Vlad CEO | 5,854 | $123.86 | 1,122,714 (Direct) | View |
| 2022-01-06 Tax Withholding | 2022-01-07 9:16 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Coric Vlad CEO | 4,634 | $128.87 | 1,122,714 (Direct) | View |
| 2021-12-31 Exercise | 2022-01-04 9:30 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Buten Matthew CFO | 12,500 | $0 | 43,677 (Direct) | View |
| 2021-12-31 Tax Withholding | 2022-01-04 9:30 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Buten Matthew CFO | 6,323 | $137.81 | 43,677 (Direct) | View |
| 2021-12-20 Option Award | 2021-12-22 9:52 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | HUGIN ROBERT J Director | 3,417 | $0 | 3,417 (Direct) | View |
| 2021-12-20 Option Award | 2021-12-22 9:51 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Heffernan Michael Thomas Director | 3,320 | $0 | 3,320 (Direct) | View |
| 2021-12-20 Exercise | 2021-12-22 9:51 pm | N/A 2027-08-01 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | GREGORY JULIA P Director | 12,000 | $0 | 0 (Direct) | View |
| 2021-12-20 Exercise | 2021-12-22 9:51 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | GREGORY JULIA P Director | 12,000 | $23.63 | 0 (Direct) | View |
| 2021-12-14 Exercise | 2021-12-16 9:04 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer | 18,500 | $10.82 | 54,649 (Direct) | View |
| 2021-12-14 Exercise | 2021-12-16 9:04 pm | N/A 2027-12-06 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer | 28,858 | $0 | 54,649 (Direct) | View |
| 2021-12-14 Exercise | 2021-12-16 9:04 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer | 10,358 | $20.79 | 54,649 (Direct) | View |
| 2021-12-08 Option Award | 2021-12-14 8:52 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Buten Matthew Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2021-12-10 Exercise | 2021-12-10 8:43 pm | N/A 2027-01-30 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James CFO | 35,000 | $0 | 94,988 (Direct) | View |
| 2021-11-25 Exercise | 2021-11-26 4:33 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 1,250 | $0 | 6,281 (Direct) | View |
| 2021-11-25 Tax Withholding | 2021-11-26 4:33 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 492 | $115.55 | 6,281 (Direct) | View |
| 2021-11-25 Exercise | 2021-11-26 4:33 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer | 3,375 | $0 | 13,029 (Direct) | View |
| 2021-11-25 Tax Withholding | 2021-11-26 4:33 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer | 1,599 | $115.55 | 13,029 (Direct) | View |
| 2021-11-25 Exercise | 2021-11-26 4:32 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease | 3,000 | $0 | 11,822 (Direct) | View |
| 2021-11-25 Tax Withholding | 2021-11-26 4:32 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease | 1,305 | $115.55 | 11,822 (Direct) | View |
| 2021-11-25 Exercise | 2021-11-26 4:30 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly VP | 3,750 | $0 | 13,453 (Direct) | View |
| 2021-11-25 Tax Withholding | 2021-11-26 4:30 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly VP | 1,738 | $115.55 | 13,453 (Direct) | View |